- REPORT SUMMARY
- TABLE OF CONTENTS
-
Pharmacovigilance (PV) market report explains the definition, types, applications, major countries, and major players of the Pharmacovigilance (PV) market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
BioClinica
iMEDGlobal
Wipro Ltd
Laboratory Corporation of America Holdings
Foresight Group International AG
ICON plc
Clinquest Group BV
United BioSource Corporation
Cognizant
ITClinical
Capgemini
Accenture
IBM Corporation
TAKE Solutions Ltd
ArisGlobal
PAREXEL International Corporation
By Type:
Spontaneous Reporting
Intensified ADR Reporting
Targeted Spontaneous Reporting
Cohort Event Monitoring
EHR Mining
By End-User:
Hospitals
Research Organizations
Industrial
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Pharmacovigilance (PV) Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Pharmacovigilance (PV) Outlook to 2028- Original Forecasts
-
2.2 Pharmacovigilance (PV) Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Pharmacovigilance (PV) Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Pharmacovigilance (PV) Market- Recent Developments
-
6.1 Pharmacovigilance (PV) Market News and Developments
-
6.2 Pharmacovigilance (PV) Market Deals Landscape
7 Pharmacovigilance (PV) Raw Materials and Cost Structure Analysis
-
7.1 Pharmacovigilance (PV) Key Raw Materials
-
7.2 Pharmacovigilance (PV) Price Trend of Key Raw Materials
-
7.3 Pharmacovigilance (PV) Key Suppliers of Raw Materials
-
7.4 Pharmacovigilance (PV) Market Concentration Rate of Raw Materials
-
7.5 Pharmacovigilance (PV) Cost Structure Analysis
-
7.5.1 Pharmacovigilance (PV) Raw Materials Analysis
-
7.5.2 Pharmacovigilance (PV) Labor Cost Analysis
-
7.5.3 Pharmacovigilance (PV) Manufacturing Expenses Analysis
8 Global Pharmacovigilance (PV) Import and Export Analysis (Top 10 Countries)
-
8.1 Global Pharmacovigilance (PV) Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Pharmacovigilance (PV) Export by Region (Top 10 Countries) (2017-2028)
9 Global Pharmacovigilance (PV) Market Outlook by Types and Applications to 2022
-
9.1 Global Pharmacovigilance (PV) Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Spontaneous Reporting Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Intensified ADR Reporting Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Targeted Spontaneous Reporting Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Cohort Event Monitoring Consumption and Growth Rate (2017-2022)
-
9.1.5 Global EHR Mining Consumption and Growth Rate (2017-2022)
-
9.2 Global Pharmacovigilance (PV) Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Research Organizations Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Industrial Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Pharmacovigilance (PV) Market Analysis and Outlook till 2022
-
10.1 Global Pharmacovigilance (PV) Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Pharmacovigilance (PV) Consumption (2017-2022)
-
10.2.2 Canada Pharmacovigilance (PV) Consumption (2017-2022)
-
10.2.3 Mexico Pharmacovigilance (PV) Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Pharmacovigilance (PV) Consumption (2017-2022)
-
10.3.2 UK Pharmacovigilance (PV) Consumption (2017-2022)
-
10.3.3 Spain Pharmacovigilance (PV) Consumption (2017-2022)
-
10.3.4 Belgium Pharmacovigilance (PV) Consumption (2017-2022)
-
10.3.5 France Pharmacovigilance (PV) Consumption (2017-2022)
-
10.3.6 Italy Pharmacovigilance (PV) Consumption (2017-2022)
-
10.3.7 Denmark Pharmacovigilance (PV) Consumption (2017-2022)
-
10.3.8 Finland Pharmacovigilance (PV) Consumption (2017-2022)
-
10.3.9 Norway Pharmacovigilance (PV) Consumption (2017-2022)
-
10.3.10 Sweden Pharmacovigilance (PV) Consumption (2017-2022)
-
10.3.11 Poland Pharmacovigilance (PV) Consumption (2017-2022)
-
10.3.12 Russia Pharmacovigilance (PV) Consumption (2017-2022)
-
10.3.13 Turkey Pharmacovigilance (PV) Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Pharmacovigilance (PV) Consumption (2017-2022)
-
10.4.2 Japan Pharmacovigilance (PV) Consumption (2017-2022)
-
10.4.3 India Pharmacovigilance (PV) Consumption (2017-2022)
-
10.4.4 South Korea Pharmacovigilance (PV) Consumption (2017-2022)
-
10.4.5 Pakistan Pharmacovigilance (PV) Consumption (2017-2022)
-
10.4.6 Bangladesh Pharmacovigilance (PV) Consumption (2017-2022)
-
10.4.7 Indonesia Pharmacovigilance (PV) Consumption (2017-2022)
-
10.4.8 Thailand Pharmacovigilance (PV) Consumption (2017-2022)
-
10.4.9 Singapore Pharmacovigilance (PV) Consumption (2017-2022)
-
10.4.10 Malaysia Pharmacovigilance (PV) Consumption (2017-2022)
-
10.4.11 Philippines Pharmacovigilance (PV) Consumption (2017-2022)
-
10.4.12 Vietnam Pharmacovigilance (PV) Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Pharmacovigilance (PV) Consumption (2017-2022)
-
10.5.2 Colombia Pharmacovigilance (PV) Consumption (2017-2022)
-
10.5.3 Chile Pharmacovigilance (PV) Consumption (2017-2022)
-
10.5.4 Argentina Pharmacovigilance (PV) Consumption (2017-2022)
-
10.5.5 Venezuela Pharmacovigilance (PV) Consumption (2017-2022)
-
10.5.6 Peru Pharmacovigilance (PV) Consumption (2017-2022)
-
10.5.7 Puerto Rico Pharmacovigilance (PV) Consumption (2017-2022)
-
10.5.8 Ecuador Pharmacovigilance (PV) Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Pharmacovigilance (PV) Consumption (2017-2022)
-
10.6.2 Kuwait Pharmacovigilance (PV) Consumption (2017-2022)
-
10.6.3 Oman Pharmacovigilance (PV) Consumption (2017-2022)
-
10.6.4 Qatar Pharmacovigilance (PV) Consumption (2017-2022)
-
10.6.5 Saudi Arabia Pharmacovigilance (PV) Consumption (2017-2022)
-
10.6.6 United Arab Emirates Pharmacovigilance (PV) Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Pharmacovigilance (PV) Consumption (2017-2022)
-
10.7.2 South Africa Pharmacovigilance (PV) Consumption (2017-2022)
-
10.7.3 Egypt Pharmacovigilance (PV) Consumption (2017-2022)
-
10.7.4 Algeria Pharmacovigilance (PV) Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Pharmacovigilance (PV) Consumption (2017-2022)
-
10.8.2 New Zealand Pharmacovigilance (PV) Consumption (2017-2022)
11 Global Pharmacovigilance (PV) Competitive Analysis
-
11.1 BioClinica
-
11.1.1 BioClinica Company Details
-
11.1.2 BioClinica Pharmacovigilance (PV) Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 BioClinica Pharmacovigilance (PV) Main Business and Markets Served
-
11.1.4 BioClinica Pharmacovigilance (PV) Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 iMEDGlobal
-
11.2.1 iMEDGlobal Company Details
-
11.2.2 iMEDGlobal Pharmacovigilance (PV) Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 iMEDGlobal Pharmacovigilance (PV) Main Business and Markets Served
-
11.2.4 iMEDGlobal Pharmacovigilance (PV) Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Wipro Ltd
-
11.3.1 Wipro Ltd Company Details
-
11.3.2 Wipro Ltd Pharmacovigilance (PV) Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Wipro Ltd Pharmacovigilance (PV) Main Business and Markets Served
-
11.3.4 Wipro Ltd Pharmacovigilance (PV) Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Laboratory Corporation of America Holdings
-
11.4.1 Laboratory Corporation of America Holdings Company Details
-
11.4.2 Laboratory Corporation of America Holdings Pharmacovigilance (PV) Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Laboratory Corporation of America Holdings Pharmacovigilance (PV) Main Business and Markets Served
-
11.4.4 Laboratory Corporation of America Holdings Pharmacovigilance (PV) Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Foresight Group International AG
-
11.5.1 Foresight Group International AG Company Details
-
11.5.2 Foresight Group International AG Pharmacovigilance (PV) Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Foresight Group International AG Pharmacovigilance (PV) Main Business and Markets Served
-
11.5.4 Foresight Group International AG Pharmacovigilance (PV) Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 ICON plc
-
11.6.1 ICON plc Company Details
-
11.6.2 ICON plc Pharmacovigilance (PV) Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 ICON plc Pharmacovigilance (PV) Main Business and Markets Served
-
11.6.4 ICON plc Pharmacovigilance (PV) Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Clinquest Group BV
-
11.7.1 Clinquest Group BV Company Details
-
11.7.2 Clinquest Group BV Pharmacovigilance (PV) Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Clinquest Group BV Pharmacovigilance (PV) Main Business and Markets Served
-
11.7.4 Clinquest Group BV Pharmacovigilance (PV) Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 United BioSource Corporation
-
11.8.1 United BioSource Corporation Company Details
-
11.8.2 United BioSource Corporation Pharmacovigilance (PV) Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 United BioSource Corporation Pharmacovigilance (PV) Main Business and Markets Served
-
11.8.4 United BioSource Corporation Pharmacovigilance (PV) Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Cognizant
-
11.9.1 Cognizant Company Details
-
11.9.2 Cognizant Pharmacovigilance (PV) Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Cognizant Pharmacovigilance (PV) Main Business and Markets Served
-
11.9.4 Cognizant Pharmacovigilance (PV) Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 ITClinical
-
11.10.1 ITClinical Company Details
-
11.10.2 ITClinical Pharmacovigilance (PV) Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 ITClinical Pharmacovigilance (PV) Main Business and Markets Served
-
11.10.4 ITClinical Pharmacovigilance (PV) Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Capgemini
-
11.11.1 Capgemini Company Details
-
11.11.2 Capgemini Pharmacovigilance (PV) Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Capgemini Pharmacovigilance (PV) Main Business and Markets Served
-
11.11.4 Capgemini Pharmacovigilance (PV) Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Accenture
-
11.12.1 Accenture Company Details
-
11.12.2 Accenture Pharmacovigilance (PV) Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Accenture Pharmacovigilance (PV) Main Business and Markets Served
-
11.12.4 Accenture Pharmacovigilance (PV) Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 IBM Corporation
-
11.13.1 IBM Corporation Company Details
-
11.13.2 IBM Corporation Pharmacovigilance (PV) Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 IBM Corporation Pharmacovigilance (PV) Main Business and Markets Served
-
11.13.4 IBM Corporation Pharmacovigilance (PV) Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 TAKE Solutions Ltd
-
11.14.1 TAKE Solutions Ltd Company Details
-
11.14.2 TAKE Solutions Ltd Pharmacovigilance (PV) Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 TAKE Solutions Ltd Pharmacovigilance (PV) Main Business and Markets Served
-
11.14.4 TAKE Solutions Ltd Pharmacovigilance (PV) Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 ArisGlobal
-
11.15.1 ArisGlobal Company Details
-
11.15.2 ArisGlobal Pharmacovigilance (PV) Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 ArisGlobal Pharmacovigilance (PV) Main Business and Markets Served
-
11.15.4 ArisGlobal Pharmacovigilance (PV) Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 PAREXEL International Corporation
-
11.16.1 PAREXEL International Corporation Company Details
-
11.16.2 PAREXEL International Corporation Pharmacovigilance (PV) Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 PAREXEL International Corporation Pharmacovigilance (PV) Main Business and Markets Served
-
11.16.4 PAREXEL International Corporation Pharmacovigilance (PV) Product Portfolio
-
11.16.5 Recent Research and Development Strategies
12 Global Pharmacovigilance (PV) Market Outlook by Types and Applications to 2028
-
12.1 Global Pharmacovigilance (PV) Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Spontaneous Reporting Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Intensified ADR Reporting Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Targeted Spontaneous Reporting Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Cohort Event Monitoring Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global EHR Mining Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Pharmacovigilance (PV) Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Research Organizations Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Industrial Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Pharmacovigilance (PV) Market Analysis and Outlook to 2028
-
13.1 Global Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.2.2 Canada Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.2.3 Mexico Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.3.2 UK Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.3.3 Spain Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.3.4 Belgium Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.3.5 France Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.3.6 Italy Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.3.7 Denmark Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.3.8 Finland Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.3.9 Norway Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.3.10 Sweden Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.3.11 Poland Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.3.12 Russia Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.3.13 Turkey Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.4.2 Japan Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.4.3 India Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.4.4 South Korea Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.4.8 Thailand Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.4.9 Singapore Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.4.11 Philippines Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.5.2 Colombia Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.5.3 Chile Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.5.4 Argentina Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.5.6 Peru Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.6.3 Oman Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.6.4 Qatar Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.7.2 South Africa Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.7.3 Egypt Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.7.4 Algeria Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Pharmacovigilance (PV) Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Pharmacovigilance (PV) Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Pharmacovigilance (PV)
-
Figure of Pharmacovigilance (PV) Picture
-
Table Global Pharmacovigilance (PV) Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Pharmacovigilance (PV) Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Spontaneous Reporting Consumption and Growth Rate (2017-2022)
-
Figure Global Intensified ADR Reporting Consumption and Growth Rate (2017-2022)
-
Figure Global Targeted Spontaneous Reporting Consumption and Growth Rate (2017-2022)
-
Figure Global Cohort Event Monitoring Consumption and Growth Rate (2017-2022)
-
Figure Global EHR Mining Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Research Organizations Consumption and Growth Rate (2017-2022)
-
Figure Global Industrial Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmacovigilance (PV) Consumption by Country (2017-2022)
-
Table North America Pharmacovigilance (PV) Consumption by Country (2017-2022)
-
Figure United States Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure Canada Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure Mexico Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Table Europe Pharmacovigilance (PV) Consumption by Country (2017-2022)
-
Figure Germany Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure UK Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure Spain Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure Belgium Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure France Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure Italy Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure Denmark Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure Finland Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure Norway Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure Sweden Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure Poland Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure Russia Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure Turkey Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Table APAC Pharmacovigilance (PV) Consumption by Country (2017-2022)
-
Figure China Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure Japan Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure India Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure South Korea Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure Thailand Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure Singapore Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure Philippines Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Table South America Pharmacovigilance (PV) Consumption by Country (2017-2022)
-
Figure Brazil Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure Colombia Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure Chile Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure Argentina Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure Peru Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Table GCC Pharmacovigilance (PV) Consumption by Country (2017-2022)
-
Figure Bahrain Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure Oman Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure Qatar Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Table Africa Pharmacovigilance (PV) Consumption by Country (2017-2022)
-
Figure Nigeria Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure South Africa Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure Egypt Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure Algeria Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Table Oceania Pharmacovigilance (PV) Consumption by Country (2017-2022)
-
Figure Australia Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Pharmacovigilance (PV) Consumption and Growth Rate (2017-2022)
-
Table BioClinica Company Details
-
Table BioClinica Pharmacovigilance (PV) Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioClinica Pharmacovigilance (PV) Main Business and Markets Served
-
Table BioClinica Pharmacovigilance (PV) Product Portfolio
-
Table iMEDGlobal Company Details
-
Table iMEDGlobal Pharmacovigilance (PV) Sales, Price, Value and Gross Profit (2017-2022)
-
Table iMEDGlobal Pharmacovigilance (PV) Main Business and Markets Served
-
Table iMEDGlobal Pharmacovigilance (PV) Product Portfolio
-
Table Wipro Ltd Company Details
-
Table Wipro Ltd Pharmacovigilance (PV) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Wipro Ltd Pharmacovigilance (PV) Main Business and Markets Served
-
Table Wipro Ltd Pharmacovigilance (PV) Product Portfolio
-
Table Laboratory Corporation of America Holdings Company Details
-
Table Laboratory Corporation of America Holdings Pharmacovigilance (PV) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Laboratory Corporation of America Holdings Pharmacovigilance (PV) Main Business and Markets Served
-
Table Laboratory Corporation of America Holdings Pharmacovigilance (PV) Product Portfolio
-
Table Foresight Group International AG Company Details
-
Table Foresight Group International AG Pharmacovigilance (PV) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Foresight Group International AG Pharmacovigilance (PV) Main Business and Markets Served
-
Table Foresight Group International AG Pharmacovigilance (PV) Product Portfolio
-
Table ICON plc Company Details
-
Table ICON plc Pharmacovigilance (PV) Sales, Price, Value and Gross Profit (2017-2022)
-
Table ICON plc Pharmacovigilance (PV) Main Business and Markets Served
-
Table ICON plc Pharmacovigilance (PV) Product Portfolio
-
Table Clinquest Group BV Company Details
-
Table Clinquest Group BV Pharmacovigilance (PV) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Clinquest Group BV Pharmacovigilance (PV) Main Business and Markets Served
-
Table Clinquest Group BV Pharmacovigilance (PV) Product Portfolio
-
Table United BioSource Corporation Company Details
-
Table United BioSource Corporation Pharmacovigilance (PV) Sales, Price, Value and Gross Profit (2017-2022)
-
Table United BioSource Corporation Pharmacovigilance (PV) Main Business and Markets Served
-
Table United BioSource Corporation Pharmacovigilance (PV) Product Portfolio
-
Table Cognizant Company Details
-
Table Cognizant Pharmacovigilance (PV) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cognizant Pharmacovigilance (PV) Main Business and Markets Served
-
Table Cognizant Pharmacovigilance (PV) Product Portfolio
-
Table ITClinical Company Details
-
Table ITClinical Pharmacovigilance (PV) Sales, Price, Value and Gross Profit (2017-2022)
-
Table ITClinical Pharmacovigilance (PV) Main Business and Markets Served
-
Table ITClinical Pharmacovigilance (PV) Product Portfolio
-
Table Capgemini Company Details
-
Table Capgemini Pharmacovigilance (PV) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Capgemini Pharmacovigilance (PV) Main Business and Markets Served
-
Table Capgemini Pharmacovigilance (PV) Product Portfolio
-
Table Accenture Company Details
-
Table Accenture Pharmacovigilance (PV) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Accenture Pharmacovigilance (PV) Main Business and Markets Served
-
Table Accenture Pharmacovigilance (PV) Product Portfolio
-
Table IBM Corporation Company Details
-
Table IBM Corporation Pharmacovigilance (PV) Sales, Price, Value and Gross Profit (2017-2022)
-
Table IBM Corporation Pharmacovigilance (PV) Main Business and Markets Served
-
Table IBM Corporation Pharmacovigilance (PV) Product Portfolio
-
Table TAKE Solutions Ltd Company Details
-
Table TAKE Solutions Ltd Pharmacovigilance (PV) Sales, Price, Value and Gross Profit (2017-2022)
-
Table TAKE Solutions Ltd Pharmacovigilance (PV) Main Business and Markets Served
-
Table TAKE Solutions Ltd Pharmacovigilance (PV) Product Portfolio
-
Table ArisGlobal Company Details
-
Table ArisGlobal Pharmacovigilance (PV) Sales, Price, Value and Gross Profit (2017-2022)
-
Table ArisGlobal Pharmacovigilance (PV) Main Business and Markets Served
-
Table ArisGlobal Pharmacovigilance (PV) Product Portfolio
-
Table PAREXEL International Corporation Company Details
-
Table PAREXEL International Corporation Pharmacovigilance (PV) Sales, Price, Value and Gross Profit (2017-2022)
-
Table PAREXEL International Corporation Pharmacovigilance (PV) Main Business and Markets Served
-
Table PAREXEL International Corporation Pharmacovigilance (PV) Product Portfolio
-
Figure Global Spontaneous Reporting Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Intensified ADR Reporting Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Targeted Spontaneous Reporting Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cohort Event Monitoring Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global EHR Mining Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Organizations Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Industrial Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharmacovigilance (PV) Consumption Forecast by Country (2022-2028)
-
Table North America Pharmacovigilance (PV) Consumption Forecast by Country (2022-2028)
-
Figure United States Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Pharmacovigilance (PV) Consumption Forecast by Country (2022-2028)
-
Figure Germany Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Pharmacovigilance (PV) Consumption Forecast by Country (2022-2028)
-
Figure China Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Pharmacovigilance (PV) Consumption Forecast by Country (2022-2028)
-
Figure Brazil Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Pharmacovigilance (PV) Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Pharmacovigilance (PV) Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Pharmacovigilance (PV) Consumption Forecast by Country (2022-2028)
-
Figure Australia Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Pharmacovigilance (PV) Consumption Forecast and Growth Rate (2022-2028)
-

Chinese